Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other financing activities (2016)

Outlook Therapeutics (OTLK) has disclosed Other financing activities for 1 consecutive years, with $40000.0 as the latest value for Q4 2016.

  • Quarterly Other financing activities changed N/A to $40000.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $40000.0 through Sep 2017, changed N/A year-over-year, with the annual reading at $823894.0 for FY2023, 37.32% up from the prior year.
  • Other financing activities for Q4 2016 was $40000.0 at Outlook Therapeutics.
  • The five-year high for Other financing activities was $40000.0 in Q4 2016, with the low at $40000.0 in Q4 2016.